MaxCyte, Inc. Inventory, Work in Process, Gross
MaxCyte, Inc. (MXCT) had Inventory, Work in Process, Gross of $571.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2026-08-13
- 2026-06-30: Inventory, Work in Process, Gross $571.00K.
- 2026-03-31: Inventory, Work in Process, Gross $642.00K.
- 2025-12-31: Inventory, Work in Process, Gross $501.00K.
- 2025-09-30: Inventory, Work in Process, Gross $400.00K.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2026-06-30 | $571.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $642.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $501.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $400.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $337.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $199.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $270.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $305.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $101.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $301.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $558.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $694.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.00M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $671.00K 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |